missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Nkx2.1 Monoclonal Antibody (8G7G3/1)

Mouse Monoclonal Antibody
Brand: Invitrogen™ MA513961
This item is not returnable.
View return policy
Description
MA5-13961 targets Thyroid Transcription Factor 1 in IF and IHC (P) applications and shows reactivity with Human, mouse, and Rat samples. The MA5-13961 immunogen is rat TTF-1 recombinant protein.
This gene encodes a protein initially identified as a thyroid-specific transcription factor. The encoded protein binds to thyroglobulin promoter and regulates the expression of thyroid-specific genes but has also been shown to regulate the expression of genes involved in morphogenesis. Mutations and deletions in this gene are associated with benign hereditary chorea, choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress, and may be associated with thyroid cancer. Multiple transcript variants encoding different isoforms have been found for this gene.
Specifications
| Nkx2.1 | |
| Monoclonal | |
| 0.2 mg/mL | |
| PBS with 0.05% BSA and 0.05% sodium azide; pH 7.4 | |
| P23441, P43699, P50220 | |
| NKX2-1 | |
| Rat TTF-1 recombinant protein. | |
| 500 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG1 κ |
| Immunohistochemistry (Paraffin) | |
| 8G7G3/1 | |
| Unconjugated | |
| NKX2-1 | |
| AV026640; BCH; BHC; homeobox protein NK-2 homolog A; Homeobox protein Nkx-2.1; NK-2; NK2 homeobox 1; NK-2 homolog A; NKX2.1; Nkx-2.1; NKX2-1; NKX2A; NMTC1; RNA polymerase I transcription termination factor; T/EBP; TEBP; Thyroid nuclear factor 1; thyroid transcription factor 1; thyroid transcription factor 1 TTF-1 NK-2; thyroid transcription factor 1-like; thyroid-specific enhancer-binding protein; tinman; TITF1; TTF1; TTF-1 | |
| Mouse | |
| Protein A/G | |
| RUO | |
| 21869, 25628, 7080 | |
| 4°C | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction